WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions

Eleanor Tyler; Achim A Jungbluth; Richard J. O'Reilly; Guenther Koehne

WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions

Eleanor Tyler, Achim A Jungbluth, Richard J. O'Reilly, Guenther Koehne

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 18 2011
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

@conference{c47a0055980d41fb81b24419577f2743,

title = "WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions",

author = "Eleanor Tyler and Jungbluth, \{Achim A\} and O'Reilly, \{Richard J.\} and Guenther Koehne",

note = "Abstract 1993 Wilm's tumor protein-1 (WT1) is over-expressed in a number of solid and hematologic malignancies including multiple myeloma (MM). The emergence of WT1-specific T cells has been shown to correlate with better relapse-free survival after allogeneic stem cell transplantation in patients (pts) with hematologic malignancies, such as leukemia.; Blood ; Conference date: 01-01-2020",

year = "2011",

month = nov,

day = "18",

language = "American English",

}

TY - CONF

T1 - WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions

AU - Tyler, Eleanor

AU - Jungbluth, Achim A

AU - O'Reilly, Richard J.

AU - Koehne, Guenther

N1 - Abstract 1993 Wilm's tumor protein-1 (WT1) is over-expressed in a number of solid and hematologic malignancies including multiple myeloma (MM). The emergence of WT1-specific T cells has been shown to correlate with better relapse-free survival after allogeneic stem cell transplantation in patients (pts) with hematologic malignancies, such as leukemia.

PY - 2011/11/18

Y1 - 2011/11/18

UR - http://www.bloodjournal.org/content/118/21/1993/tab-article-info?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions

Conference

Disciplines

Other files and links

Cite this